Pipeline

Vidac has built a portfolio of novel product candidates that target significant unmet medical needs in oncology and dermatology.

read more

News

Vidac Pharma Secures EUR 20m Capital Commitment From GEM

VIDAC PHARMA ANNOUNCES INCLUSION OF THE FIRST PATIENT IN A PLACEBO CONTROLLED PHASE II STUDY

VIDAC PHARMA ANNOUNCES PUBLICATION OF A PEER REVIEWED ARTICLE ON VDA-1102 MECHANISM OF ACTION

VIDAC PHARMA TO PRESENT A POSTER AT THE SITC 2018 MEETING